Last 12 months
Inside the activity.
9 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 3 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 3 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2025 Filed Sep 10, 2025 10:32 UTC |
Carrico Brian AllenDirector · Chief Executive Officer
|
GrantRSU · Derivative | 90,640 | $2.18 | $197,595.20 |
DisclosureSEC source: 0001641172-25-027017 · ownership.xml · derivative · entry 2 Carrico Brian Allen · CIK 0001959279 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,640 Underlying: Common Stock · 90,640 shares Expires not disclosed F2 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F2 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F2 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. Read SEC document |
| March 04, 2025 Filed Sep 10, 2025 10:32 UTC |
Carrico Brian AllenDirector · Chief Executive Officer
|
GrantRSU · Derivative | 10,000 | $2.18 | $21,800.00 |
DisclosureSEC source: 0001641172-25-027017 · ownership.xml · derivative · entry 1 Carrico Brian Allen · CIK 0001959279 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. F1 · derivative.exercise_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. F1 · derivative.expiration_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. Read SEC document |
| March 04, 2025 Filed Sep 10, 2025 10:32 UTC |
Miranda AdrianCMO, SVP Science & Tech
|
GrantRSU · Derivative | 30,000 | $2.18 | $65,400.00 |
DisclosureSEC source: 0001641172-25-027022 · ownership.xml · derivative · entry 2 Miranda Adrian · CIK 0001992525 · CMO, SVP Science & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F2 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F2 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F2 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. Read SEC document |
| March 04, 2025 Filed Sep 10, 2025 10:32 UTC |
Miranda AdrianCMO, SVP Science & Tech
|
GrantRSU · Derivative | 10,000 | $2.18 | $21,800.00 |
DisclosureSEC source: 0001641172-25-027022 · ownership.xml · derivative · entry 1 Miranda Adrian · CIK 0001992525 · CMO, SVP Science & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. F1 · derivative.exercise_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. F1 · derivative.expiration_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. Read SEC document |
| March 04, 2025 Filed Sep 10, 2025 10:32 UTC |
Carrico Thomas JoesephCRO, CCO, CPO
|
GrantRSU · Derivative | 27,435 | $2.18 | $59,808.30 |
DisclosureSEC source: 0001641172-25-027018 · ownership.xml · derivative · entry 2 Carrico Thomas Joeseph · CIK 0001959325 · CRO, CCO, CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,435 Underlying: Common Stock · 27,435 shares Expires not disclosed F2 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F2 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F2 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. Read SEC document |
| March 04, 2025 Filed Sep 10, 2025 10:32 UTC |
Carrico Thomas JoesephCRO, CCO, CPO
|
GrantRSU · Derivative | 10,000 | $2.18 | $21,800.00 |
DisclosureSEC source: 0001641172-25-027018 · ownership.xml · derivative · entry 1 Carrico Thomas Joeseph · CIK 0001959325 · CRO, CCO, CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. F1 · derivative.exercise_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. F1 · derivative.expiration_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months. Read SEC document |
| January 17, 2025 Filed Sep 10, 2025 10:32 UTC |
Keyser Jane ElizabethDirector
|
GrantCommon Stock | 13,157 | $2.85 | $37,497.45 |
DisclosureSEC source: 0001641172-25-027021 · ownership.xml · nonDerivative · entry 1 Keyser Jane Elizabeth · CIK 0001959756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,737 F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. Read SEC document |
| January 17, 2025 Filed Sep 10, 2025 10:32 UTC |
Ferge Kristin ADirector
|
GrantCommon Stock | 13,157 | $2.85 | $37,497.45 |
DisclosureSEC source: 0001641172-25-027019 · ownership.xml · nonDerivative · entry 1 Ferge Kristin A · CIK 0001343345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,340 F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. Read SEC document |
| January 17, 2025 Filed Sep 10, 2025 10:32 UTC |
Watkins Bradley MitchellDirector
|
GrantCommon Stock | 13,157 | $2.85 | $37,497.45 |
DisclosureSEC source: 0001641172-25-027023 · ownership.xml · nonDerivative · entry 1 Watkins Bradley Mitchell · CIK 0001959534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,737 F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. Read SEC document |
| January 03, 2025 Filed Sep 10, 2025 10:32 UTC |
Henrichs Timothy RobertChief Financial Officer
|
GrantRSU · Derivative | 67,980 | $2.42 | $164,511.60 |
DisclosureSEC source: 0001641172-25-027020 · ownership.xml · derivative · entry 4 Henrichs Timothy Robert · CIK 0001959954 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,980 Underlying: Common Stock · 67,980 shares Expires not disclosed F4 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F4 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F4 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. Read SEC document |
| January 03, 2025 Filed Sep 10, 2025 10:32 UTC |
Carrico Brian AllenDirector · Chief Executive Officer
|
GrantRSU · Derivative | 70,019 | $2.42 | $169,445.98 |
DisclosureSEC source: 0001641172-25-027017 · ownership.xml · derivative · entry 3 Carrico Brian Allen · CIK 0001959279 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,019 Underlying: Common Stock · 70,019 shares Expires not disclosed F3 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F3 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F3 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. Read SEC document |
| January 03, 2025 Filed Sep 10, 2025 10:32 UTC |
Miranda AdrianCMO, SVP Science & Tech
|
GrantRSU · Derivative | 35,000 | $2.42 | $84,700.00 |
DisclosureSEC source: 0001641172-25-027022 · ownership.xml · derivative · entry 3 Miranda Adrian · CIK 0001992525 · CMO, SVP Science & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F3 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F3 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F3 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. Read SEC document |
| January 03, 2025 Filed Sep 10, 2025 10:32 UTC |
Carrico Thomas JoesephCRO, CCO, CPO
|
GrantRSU · Derivative | 35,000 | $2.42 | $84,700.00 |
DisclosureSEC source: 0001641172-25-027018 · ownership.xml · derivative · entry 3 Carrico Thomas Joeseph · CIK 0001959325 · CRO, CCO, CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F3 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F3 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. F3 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 19:16 UTC |
Keyser Jane ElizabethDirector
|
GrantCommon Stock, par value $0.001 | 11,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-025970 · ownership.xml · nonDerivative · entry 1 Keyser Jane Elizabeth · CIK 0001959756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,580 F1 · kind: These shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), were issued to Ms. Keyser pursuant to an Unrestricted Stock Award Agreement dated June 28, 2024 (the "Agreement"), by and between NeurAxis, Inc. (the "Company") and Ms. Keyser. Pursuant to the Agreement, as compensation for the services provided as a member of the Board of Directors of the Company by Ms. Keyser through March 31, 2024, the Company issued Ms. Keyser the number of shares of Common Stock as determined by dividing $32,191.78 by the closing price of the Common Stock on June 28, 2024, which was $2.78 per share. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 19:18 UTC |
Ferge Kristin ADirector
|
GrantCommon Stock, par value $0.001 | 1,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-025972 · ownership.xml · nonDerivative · entry 1 Ferge Kristin A · CIK 0001343345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,183 F1 · kind: These shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), were issued to Ms. Ferge pursuant to an Unrestricted Stock Award Agreement dated June 28, 2024 (the "Agreement"), by and between NeurAxis, Inc. (the "Company") and Ms. Ferge. Pursuant to the Agreement, as compensation for the services provided as a member of the Board of Directors of the Company by Ms. Ferge through March 31, 2024, the Company issued Ms. Ferge the number of shares of Common Stock as determined by dividing $3,287.67 by the closing price of the Common Stock on June 28, 2024, which was $2.78 per share. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 19:13 UTC |
Watkins Bradley MitchellDirector
|
GrantCommon Stock, par value $0.001 | 11,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-025968 · ownership.xml · nonDerivative · entry 1 Watkins Bradley Mitchell · CIK 0001959534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,580 F1 · kind: These shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), were issued to Mr. Watkins pursuant to an Unrestricted Stock Award Agreement dated June 28, 2024 (the "Agreement"), by and between NeurAxis, Inc. (the "Company") and Mr. Watkins. Pursuant to the Agreement, as compensation for the services provided as a member of the Board of Directors of the Company by Mr. Watkins through March 31, 2024, the Company issued Mr. Watkins the number of shares of Common Stock as determined by dividing $32,191.78 by the closing price of the Common Stock on June 28, 2024, which was $2.78 per share. Read SEC document |
| February 20, 2024 Filed Feb 29, 2024 15:14 UTC |
Hannasch Brian10% owner
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006005 · rdgdoc.xml · nonDerivative · entry 1 Hannasch Brian · CIK 0001911504 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 757,901 F1 · kind: On February 20, 2024, the reporting person received 75,000 shares of common stock of Neuraxis, Inc. pursuant to the terms of a Consulting Agreement dated December 27, 2023. Read SEC document |
| February 06, 2024 Filed Feb 14, 2024 21:30 UTC |
Hannasch Brian10% owner
|
OtherCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004168 · rdgdoc.xml · nonDerivative · entry 1 Hannasch Brian · CIK 0001911504 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682,901 F1 · kind: On February 6, 2024, the reporting person received an aggregate of 150,000 shares of Neuraxis, Inc. (the "Company") common stock from directors and officers of the Company pursuant to the terms of a promissory note dated August 1, 2023. Read SEC document |
| December 28, 2023 Filed Jan 23, 2024 21:06 UTC |
Hannasch Brian10% owner
|
OtherWarrant (right to purchase) · Derivative | 40,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001437749-24-001951 · rdgdoc.xml · derivative · entry 3 Hannasch Brian · CIK 0001911504 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2029-09-06 Read SEC document |
| December 28, 2023 Filed Jan 23, 2024 21:06 UTC |
Hannasch Brian10% owner
|
SaleCommon Stock | 76 | $2.61 | $198.36 |
DisclosureSEC source: 0001437749-24-001951 · rdgdoc.xml · nonDerivative · entry 2 Hannasch Brian · CIK 0001911504 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 532,901 F1 · kind: On December 28, 2023, the reporting person exercised a warrant to purchase 40,000 shares of Neuraxis, Inc. (the "Company") common stock for $0.005 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company withholding 76 of the warrant shares to pay the exercise price and issuing the reporting person the remaining 39,924 shares. Read SEC document |
| December 28, 2023 Filed Jan 23, 2024 21:06 UTC |
Hannasch Brian10% owner
|
OtherCommon Stock | 40,000 | $0.01 | $200.00 |
DisclosureSEC source: 0001437749-24-001951 · rdgdoc.xml · nonDerivative · entry 1 Hannasch Brian · CIK 0001911504 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 532,977 Read SEC document |
| August 11, 2023 Filed Aug 11, 2023 23:42 UTC Amendment |
MASIMO CORP10% owner
|
ConversionPre-Funded Warrant, Common Stock (Right to Buy) · Derivative | 289,779 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000937556-23-000202 · wf-form4a_169179734438990.xml · derivative · entry 4 MASIMO CORP · CIK 0000937556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,779 Underlying: Common Stock · 289,779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. F2 · derivative.expiration_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. Read SEC document |
| August 11, 2023 Filed Aug 11, 2023 23:42 UTC Amendment |
MASIMO CORP10% owner
|
ConversionPre-Funded Warrant, Series A Preferred Stock (Right to Buy) · Derivative | 144,890 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000937556-23-000202 · wf-form4a_169179734438990.xml · derivative · entry 3 MASIMO CORP · CIK 0000937556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series A Preferred Stock · 144,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. F2 · derivative.expiration_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. F2 · derivative.underlying_shares: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. Read SEC document |
| August 11, 2023 Filed Aug 11, 2023 23:42 UTC Amendment |
MASIMO CORP10% owner
|
ConversionSeries A Preferred Stock · Derivative | 265,774 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-23-000202 · wf-form4a_169179734438990.xml · derivative · entry 2 MASIMO CORP · CIK 0000937556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 531,548 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. F1 · derivative.underlying_shares: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. Read SEC document |
| August 11, 2023 Filed Aug 11, 2023 23:42 UTC Amendment |
MASIMO CORP10% owner
|
ConversionCommon Stock | 531,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000937556-23-000202 · wf-form4a_169179734438990.xml · nonDerivative · entry 1 MASIMO CORP · CIK 0000937556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. Read SEC document |
| August 10, 2023 Filed Aug 10, 2023 21:16 UTC |
MASIMO CORP10% owner
|
ConversionPre-Funded Warrant, Common Stock (Right to Buy) · Derivative | 289,779 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000937556-23-000199 · wf-form4_169170219111216.xml · derivative · entry 4 MASIMO CORP · CIK 0000937556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,779 Underlying: Common Stock · 289,779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. F2 · derivative.expiration_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. Read SEC document |
| August 10, 2023 Filed Aug 10, 2023 21:16 UTC |
MASIMO CORP10% owner
|
ConversionPre-Funded Warrant, Series A Preferred Stock (Right to Buy) · Derivative | 144,890 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000937556-23-000199 · wf-form4_169170219111216.xml · derivative · entry 3 MASIMO CORP · CIK 0000937556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series A Preferred Stock · 144,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. F2 · derivative.expiration_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. F2 · derivative.underlying_shares: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. Read SEC document |
| August 10, 2023 Filed Aug 10, 2023 21:16 UTC |
MASIMO CORP10% owner
|
ConversionSeries A Preferred Stock · Derivative | 265,774 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-23-000199 · wf-form4_169170219111216.xml · derivative · entry 2 MASIMO CORP · CIK 0000937556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 531,548 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. F1 · derivative.underlying_shares: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. Read SEC document |
| August 10, 2023 Filed Aug 10, 2023 21:16 UTC |
MASIMO CORP10% owner
|
ConversionCommon Stock | 531,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000937556-23-000199 · wf-form4_169170219111216.xml · nonDerivative · entry 1 MASIMO CORP · CIK 0000937556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.